Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colon Cancer (Stage II &Amp; III)”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableStudy completedNCT01346280
What this trial is testing

Evaluation of Cancer Care Coordination in the National Cancer Institutes Community Cancer Center Programs

Who this might be right for
Non-Small Cell Lung Cancer (Stage III)Colon Cancer (Stage II &Amp; III)Rectal Cancer (Stage III)
National Cancer Institute (NCI) 1,079
Large-scale testing (Phase 3)Looking for participantsNCT06609551
What this trial is testing

CtDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: a Single-center, Randomized, Controlled Study

Who this might be right for
Colon CancerColon Cancer (stage II & III)
Zhejiang Cancer Hospital 312
Not applicableLooking for participantsNCT07161713
What this trial is testing

SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors

Who this might be right for
Lung AdenocarcinomaLung Adenocarcinoma MetastaticLung Adenocarcinoma Stage III+8 more
Barbara Nemesure 100
Not applicableNot Yet RecruitingNCT07413146
What this trial is testing

Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial

Who this might be right for
Minimal Residual DiseaseImmunoscoreNeoadjuvant Chemotherapy+1 more
Sun Yat-sen University 100
Not applicableStudy completedNCT07012538
What this trial is testing

RASi for Preventing Postoperative Recurrence of Stage II/III Colon Cancer

Who this might be right for
Colon Cancer (Stage II &Amp;Amp; III)
Fudan University 2,640
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06890624
What this trial is testing

MFOLFOXIRI Plus PD-1 Inhibitor Vs MFOLFOX6 As Neoadjuvant Therapy for Locally Advanced Colon Cancer

Who this might be right for
Colon Cancer (stage II & III)
Sun Yat-sen University 138